nach oben

Diabetologia

Erschienen in:

01.03.2012 | Article

Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study

verfasst von: T. Lind, I. Waernbaum, Y. Berhan, G. Dahlquist

Erschienen in: Diabetologia | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Mood disorders, including depression, are suggested to be prevalent in persons with type 1 diabetes and may negatively affect self-management and glycaemic control and increase the risk of diabetic complications. The aim of this study was to analyse the prevalence of antidepressant (AD) use in adults with childhood onset type 1 diabetes and to compare risk determinants for AD prescription among diabetic patients and a group of matched controls.

Methods

Young adults ≥18 years on 1 January 2006 with type 1 diabetes (n = 7,411) were retrieved from the population-based Swedish Childhood Diabetes Registry (SCDR) and compared with 30,043 age- and community-matched controls. Individual level data were collected from the Swedish National Drug Register (NDR), the Hospital Discharge Register (HDR) and the Labor Market Research database (LMR).

Results

ADs were prescribed to 9.5% and 6.8% of the type 1 diabetes and control subjects, respectively. Female sex, having received economic or other social support, or having a disability pension were the factors with the strongest association with AD prescription in both groups. Type 1 diabetes was associated with a 44% (OR 1.44, 95% CI 1.32, 1.58) higher risk of being prescribed ADs in crude analysis. When adjusting for potential confounders including sex, age and various socioeconomic risk factors, this risk increase was statistically non-significant (OR 1.11, 95% CI 0.99, 1.21).

Conclusions/interpretation

The risk factor patterns for AD use are similar among type 1 diabetic patients and controls, and socioeconomic risk factors, rather than the diabetes per se, contribute to the increased risk of AD use in young adults with type 1 diabetes.

Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed

van Tilburg MA, McCaskill CC, Lane JD et al (2001) Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 63:551–555PubMed

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMedCrossRef

Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 23:445–448PubMedCrossRef

Lawrence JM, Standiford DA, Loots B et al (2006) Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth Study. Pediatrics 117:1348–1358PubMedCrossRef

Kovacs M, Goldston D, Obrosky DS, Bonar LK (1997) Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 20:36–44PubMedCrossRef

Popkin MK, Callies AL, Lentz RD, Colon EA, Sutherland de (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 45:64–68PubMedCrossRef

Petrak F, Hardt J, Wittchen HU et al (2003) Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev 19:216–222PubMedCrossRef

Kokkonen E-R (1995) Mental health and social adaptation in young adults with juvenile-onset diabetes. Nordic J Psychiatr 49:175–181CrossRef

10.

Lustman PJ, Griffith LS, Clouse RE et al (1995) Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. Diabetes Care 18:1133–1139PubMedCrossRef

11.

Lustman PJ, Griffith LS, Clouse RE et al (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250PubMed

12.

Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE (1997) Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31PubMed

13.

Garrison CZ, Addy CL, Jackson KL, McKeown RE, Waller JL (1992) Major depressive disorder and dysthymia in young adolescents. Am J Epidemiol 135:792–802PubMed

14.

Goodman E (1999) The role of socioeconomic status gradients in explaining differences in US adolescents’ health. Am J Public Health 89:1522–1528PubMedCrossRef

15.

Roberts RE, Roberts CR, Chen YR (1997) Ethnocultural differences in prevalence of adolescent depression. Am J Community Psychol 25:95–110PubMedCrossRef

16.

Hansen DG, Sondergaard J, Vach W et al (2004) Socio-economic inequalities in first-time use of antidepressants: a population-based study. Eur J Clin Pharmacol 60:51–55PubMedCrossRef

17.

Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G (2011) Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 60:577–581PubMedCrossRef

18.

Dahlquist G, Mustonen L (2000) Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. Acta Paediatr 89:1231–1237PubMedCrossRef

19.

Wallgren A, Wallgren B (2007) Register-based statistics: administrative data for statistical purposes. Wiley, Chichester

20.

The National Board of Health and Welfare (2011). www.socialstyrelsen.se/english. Accessed 9 September 2011

21.

Statistics Sweden (2011). www.scb.se/default____2154.aspx. Accessed 9 September 2011

22.

The National Board of Health and Welfare (2003) A finger on the pulse. Monitoring public health and social conditions in Sweden 1992–2002. In: Rosén M (ed). The National Board of Health and Welfare, Stockholm

23.

Ury HK (1975) Efficiency of case–control studies with multiple controls per case: continuous or dichotomous data. Biometrics 31:643–649PubMedCrossRef

24.

World Health Organization Collaborating Centre for Drug Statistics Methodology (2011) ATC/DDD Index 2011. www.whocc.no/. Accessed 9 September 2011

25.

The National Board of Health and Welfare (2007) Pharmaceuticals—statistics for 2006. In: Eriksson Ö (ed). The National Board of Health and Welfare, Stockholm

26.

Statistics Sweden (2011) Background facts, labour and education statistics 2011:4. In: Integrated database for labour market research. SCB, Stockholm

27.

World Health Organization (2007) International statistical classification of diseases and related health problems, 10th revision. http://apps.who.int/classifications/apps/icd/icd10online/. Accessed 9 September 2011

28.

Inspektionen för socialförsäkringen (2011) Unga med aktivitetsersättning. In: Inspektionen för socialförsäkringen, Stockholm (in Swedish)

29.

Li X, Sundquist J, Sundquist K (2008) Age-specific familial risks of depression: a nation-wide epidemiological study from Sweden. J Psychiatr Res 42:808–814PubMedCrossRef

30.

Barrera MJ, Prelow HM, Dumka LE et al (2002) Pathways from family economic conditions to adolescents’ distress: supportive parenting, stressors outside the family, and deviant peers. J Community Psychol 30:135–152CrossRef

31.

Currie J (2009) Healthy, wealthy, and wise: socioeconomic status, poor health in childhood, and human capital development. J Econ Lit 47:87–122CrossRef

32.

Sundquist K, Johansson LM, Johansson SE, Sundquist J (2004) Social environment and psychiatric illness. A follow-up study of 9,170 women and men in Sweden. Soc Psychiatr Psychiatr Epidemiol 39:39–44CrossRef

33.

Milton B, Holland P, Whitehead M (2006) The social and economic consequences of childhood-onset type 1 diabetes mellitus across the lifecourse: a systematic review. Diabet Med 23:821–829PubMedCrossRef

34.

Kakleas K, Kandyla B, Karayianni C, Karavanaki K (2009) Psychosocial problems in adolescents with type 1 diabetes mellitus. Diabetes Metab 35:339–350PubMedCrossRef

35.

Dahlquist G, Kallen B (2007) School performance in children with type 1 diabetes—a population-based register study. Diabetologia 50:957–964PubMedCrossRef

36.

Dahlquist G, Kallen B (2007) School marks for Swedish children whose mothers had diabetes during pregnancy: a population-based study. Diabetologia 50:1826–1831PubMedCrossRef

37.

Henriksson S, Boethius G, Hakansson J, Isacsson G (2003) Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995. Acta Psychiatr Scand 108:427–431PubMedCrossRef

38.

van der Feltz-Cornelis CM, Nuyen J, Stoop C et al (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32:380–395PubMedCrossRef

39.

Manderbacka K, Sund R, Koski S, Keskimaki I, Elovainio M (2011) Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997–2007. Pharmacoepidemiol Drug Saf 20:338–343PubMedCrossRef

40.

Sundell KA, Gissler M, Petzold M, Waern M (2011) Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years. Eur J Clin Pharmacol 67:169–178PubMedCrossRef

41.

Gendelman N, Snell-Bergeon JK, McFann K et al (2009) Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 32:575–579PubMedCrossRef

Titel: Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study
verfasst von: T. Lind
I. Waernbaum
Y. Berhan
G. Dahlquist
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 3/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2405-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Novel versus traditional risk markers for diabetic retinopathy

Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle

Erratum to: Audit of acute Charcot’s disease in the UK: the CDUK study

INS GFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells

Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease

Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin